Evidence map›Paper›PMID 32092883›Full record

ArticleBiomedicines2020

Addition of K22 Converts Spider Venom Peptide Pme2a from an Activator to an Inhibitor of Na

Kathleen Yin, Jennifer R Deuis, Zoltan Dekan, Ai-Hua Jin, Paul F Alewood, Glenn F King, Volker Herzig, Irina Vetter

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Animal Venoms-Curse or Cure?Biomedicines · 2021
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kathleen YinCentre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, North Ryde, NSW 2109, Australia.
Jennifer R DeuisInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Zoltan DekanInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Ai-Hua JinInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Paul F AlewoodInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Glenn F KingInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Volker HerzigInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
Irina VetterInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
The University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spider venom is a novel source of disulfide-rich peptides with potent and selective activity at voltage-gated sodium channels (Na

Indexed as

NaV1.7NaV1.8peptidesodium channelspidervenom

Identifiers

PMID32092883
PMCPMC7167818
OpenAlexW3008061540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.